Search clinical trials for: Safinamide Levodopa
Total 334 results
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH); Columbia UniversitySuspendedDepressive DisorderUnited States
-
Bial - Portela C S.A.Completed
-
Huashan HospitalBoehringer IngelheimCompletedIdiopathic Parkinson's DiseaseChina
-
Uppsala UniversitySwedish Society for Medical Research; Swedish Parkinson's Disease FoundationCompletedParkinson Disease | DyskinesiasSweden
-
Sumitomo Pharma Co., Ltd.CompletedParkinson's Disease | Levodopa-induced DyskinesiaJapan
-
The University of Texas Health Science Center,...National Institute on Drug Abuse (NIDA)CompletedCocaine DependenceUnited States
-
Orion Corporation, Orion PharmaCompleted
-
University of MichiganNational Institute on Aging (NIA)RecruitingParkinsonian Signs in Older PersonsUnited States
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.CompletedParkinson's DiseasePortugal, Romania, Ukraine
-
Emory UniversityNational Institute of Mental Health (NIMH)Completed
-
SynAgile CorporationTFS Trial Form Support; Clintrex Research Corporation; Clinical Data Science...CompletedParkinson's DiseaseItaly, Luxembourg, Spain
-
Institute for Neurodegenerative DisordersUnited States Department of Defense; Boehringer IngelheimCompletedParkinson Disease | Parkinsonian SyndromeUnited States
-
University of ZurichSwiss Federal Institute of TechnologyCompletedHealthy | Schizotypal PersonalitySwitzerland
-
National Institute of Neurological Disorders and...Completed
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)Completed
-
VA Office of Research and DevelopmentEmory UniversityEnrolling by invitation
-
Bial - Portela C S.A.CompletedParkinson DiseaseUnited Kingdom
-
Boston Children's HospitalCompletedAngelman SyndromeUnited States
-
Boehringer IngelheimCompleted
-
Impax Laboratories, LLCCompletedIdiopathic Parkinson's DiseaseUnited States
-
Hong Kong WD Pharmaceutical Co., LimitedUnknown
-
Merck Sharp & Dohme LLCCompletedParkinson's Disease
-
Eisai Inc.AvailableAn Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303Lennox Gastaut SyndromePoland
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingAcute Stroke | Stroke RehabilitationSwitzerland
-
Ross D. Zafonte, MDWithdrawnStrokeUnited States
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)CompletedAmblyopiaUnited States
-
National Institute of Neurological Disorders and...Completed
-
National Institute of Neurological Disorders and...CompletedParkinson's DiseaseUnited States
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
AbbVieCompletedAdvanced Parkinson's DiseaseUnited States, Australia, Canada, Germany, Greece, Italy, Korea, Republic of, Spain, Sweden
-
New York State Psychiatric InstituteCompletedCocaine DependenceUnited States
-
NovartisCompletedParkinson's DiseasePhilippines, Thailand, Australia, Taiwan
-
Acorda TherapeuticsCompleted
-
PfizerTerminatedParkinson DiseaseAustralia, Italy, Spain
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.CompletedParkinson DiseaseCanada
-
Eisai Co., Ltd.CompletedLennox-Gastaut SyndromeJapan
-
Eisai Co., Ltd.Completed
-
Orion Corporation, Orion PharmaCompleted
-
Mostafa BahaaSahar Mohamed El-Haggar clinical pharmacy department, Tanta University; Sahar... and other collaboratorsRecruiting
-
NeuroDerm Ltd.Completed
-
Bial - Portela C S.A.CompletedParkinson's Disease (PD)Portugal
-
Orion Corporation, Orion PharmaCompleted
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaUnknown
-
Bial - Portela C S.A.CompletedParkinson's Disease (PD)France
-
National Institute of Neurological Disorders and...Completed